Corcept Therapeutics CORT
NASDAQ CORT
$116.23 +2.20 (+1.93%)
At close: Oct 2, 2026 · 4:00 PM EDT

Corcept Therapeutics (CORT) Consolidated Net Income (2010 - 2026)

Updated

Corcept Therapeutics' Consolidated Net Income came in at $42.99 million for Q2 2026, up 22.1% from $35.19 million a year earlier.

Analysis

Corcept Therapeutics (CORT) Consolidated Net Income (2010 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Corcept Therapeutics reported Consolidated Net Income of $55.23 million, down 58.7% year-over-year; for FY2025, it came in at $99.65 million, down 29.4% from FY2024.

  • Consolidated Net Income carries a five-year compound annual growth rate of -1.2% (FY2020 to FY2025).
  • Going back by year, Consolidated Net Income was $141.21 million in FY2024 (+33.0%), $106.14 million in FY2023 (+4.7%), $101.42 million in FY2022 (-9.9%) and $112.51 million in FY2021 (+6.1%).
  • The Q2 2026 figure represents the highest quarterly Consolidated Net Income since Q3 2024.
  • Year-over-year, Consolidated Net Income increased in two of the last seven quarters, with an average decline of 5.1%.
  • The fastest year-over-year change in Consolidated Net Income over five years came in Q4 2023 (growth of 89.1%), and the weakest in Q3 2025 (a decline of 58.3%).
  • Business Quant data shows CORT's Consolidated Net Income at -$31.72 million (Q1 2026), $24.29 million (Q4 2025) and $19.67 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Consol Net Inc. (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 7.10 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 5.53 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 3.62 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -1.34 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 3.26 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 2.51 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 2.38 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -10.50 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -237.00 Mn
10 Corcept Therapeutics 12.56 Bn 11.12 Bn 252.09 Mn 42.99 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 42.99 Mn
Mar 31, 2026 -31.72 Mn
Dec 31, 2025 24.29 Mn
Sep 30, 2025 19.67 Mn
Jun 30, 2025 35.19 Mn
Mar 31, 2025 20.55 Mn
Dec 31, 2024 30.78 Mn
Sep 30, 2024 47.21 Mn
Jun 30, 2024 35.49 Mn
Mar 31, 2024 27.76 Mn
Dec 31, 2023 31.39 Mn
Sep 30, 2023 31.38 Mn
Jun 30, 2023 27.53 Mn
Mar 31, 2023 15.83 Mn
Dec 31, 2022 16.60 Mn
Sep 30, 2022 34.61 Mn
Jun 30, 2022 27.36 Mn
Mar 31, 2022 22.75 Mn
Dec 31, 2021 32.05 Mn
Sep 30, 2021 30.47 Mn
API Access

Corcept Therapeutics Consolidated Net Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=consolidated-net-income&ticker=CORT&period=max&api_key=YOUR_API_KEY